Suchergebnisse - "Southgate, Harriet"

PubPharm (6)

1

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Illuzzi, G. | Staniszewska, A. | Gill, S. | +19

2

Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells

enthalten in: Cancers | 2021

von King, D. | Southgate, H. | Roetschke, S. | +10

3

DNA damage checkpoint kinases in cancer

enthalten in: Expert reviews in molecular medicine | 2020

von Smith, H. | Southgate, H. | Tweddle, D. | +1

4

ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms

enthalten in: Cancers | 2020

von Southgate, H. | Chen, L. | Tweddle, D. | +1

5

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

enthalten in: Frontiers in oncology | 2020

von Southgate, H. | Chen, L. | Curtin, N. | +1

6

The Nonanes. 2-Methyloctane, 3-Ethylheptane, 2,3-Dimethylheptane and 2,2,4,4-Tetramethylpentane1

in: Journal of the American Chemical Society | 1938

von Whitmore, F. | Southgate, H.

1
[1]